Increasing Global Support for Breastfeeding Can Save 515,000 Lives and $1.5 Billion Daily 04/08/2022 Raisa Santos Nearly $575 million in global economic and human capital is lost every year due to insufficient government promotion of, and support for, breastfeeding, according to data from the latest report on The Cost of Not Breastfeeding. The 2022 report, released for World Breastfeeding Week (1 August – 7 August) finds that these losses are the […] Continue reading -> WHO Launches Appeal To Respond to Food Crisis in Horn of Africa 03/08/2022 Raisa Santos In light of an unprecedented food crisis in the Horn of Africa, the World Health Organization has launched a $123.7 million funding appeal for urgently needed supplies to treat severe malnutrition and related health conditions. Driven by conflict, changes in climate and the COVID-19 pandemic, this largely arid Eastern African region of some 2 million […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> New Allies Tackle Scourge of AIDS in Kids 02/08/2022 John Heilprin Twelve African nations have joined with the United Nations and other international organizations in forming a new alliance that will work to prevent new infant HIV infections and to ensure no child living with HIV is denied treatment by the end of the decade. Proponents of the new Global Alliance for Ending AIDS in Children […] Continue reading -> Human Rights is a ‘Battlefield’ as Global Discrimination Fuels New HIV Infections 01/08/2022 Kerry Cullinan MONTREAL – HIV is one of the most studied diseases of all time and an arsenal of treatment and prevention tools have been amassed over the past 40 years – the latest being an antiretroviral (ARV) injection taken every eight weeks that can prevent 99% of infections. But HIV is still spreading – primarily amongst […] Continue reading -> ‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Launches Appeal To Respond to Food Crisis in Horn of Africa 03/08/2022 Raisa Santos In light of an unprecedented food crisis in the Horn of Africa, the World Health Organization has launched a $123.7 million funding appeal for urgently needed supplies to treat severe malnutrition and related health conditions. Driven by conflict, changes in climate and the COVID-19 pandemic, this largely arid Eastern African region of some 2 million […] Continue reading -> High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> New Allies Tackle Scourge of AIDS in Kids 02/08/2022 John Heilprin Twelve African nations have joined with the United Nations and other international organizations in forming a new alliance that will work to prevent new infant HIV infections and to ensure no child living with HIV is denied treatment by the end of the decade. Proponents of the new Global Alliance for Ending AIDS in Children […] Continue reading -> Human Rights is a ‘Battlefield’ as Global Discrimination Fuels New HIV Infections 01/08/2022 Kerry Cullinan MONTREAL – HIV is one of the most studied diseases of all time and an arsenal of treatment and prevention tools have been amassed over the past 40 years – the latest being an antiretroviral (ARV) injection taken every eight weeks that can prevent 99% of infections. But HIV is still spreading – primarily amongst […] Continue reading -> ‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
High Income Countries Cast Wide Net In Monkeypox Vaccination – As Researchers Scramble for Real-Life Data on Efficacy 02/08/2022 Elaine Ruth Fletcher High income countries like the United States and Canada are casting a wide net in their vaccine strategy for monkeypox, vaccinating people exposed to an infected case and groups at risk of exposure while scrambling to study the results in terms of efficacy. That was the upshot of a WHO-sponsored symposium on monkeypox research involving […] Continue reading -> New Allies Tackle Scourge of AIDS in Kids 02/08/2022 John Heilprin Twelve African nations have joined with the United Nations and other international organizations in forming a new alliance that will work to prevent new infant HIV infections and to ensure no child living with HIV is denied treatment by the end of the decade. Proponents of the new Global Alliance for Ending AIDS in Children […] Continue reading -> Human Rights is a ‘Battlefield’ as Global Discrimination Fuels New HIV Infections 01/08/2022 Kerry Cullinan MONTREAL – HIV is one of the most studied diseases of all time and an arsenal of treatment and prevention tools have been amassed over the past 40 years – the latest being an antiretroviral (ARV) injection taken every eight weeks that can prevent 99% of infections. But HIV is still spreading – primarily amongst […] Continue reading -> ‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Allies Tackle Scourge of AIDS in Kids 02/08/2022 John Heilprin Twelve African nations have joined with the United Nations and other international organizations in forming a new alliance that will work to prevent new infant HIV infections and to ensure no child living with HIV is denied treatment by the end of the decade. Proponents of the new Global Alliance for Ending AIDS in Children […] Continue reading -> Human Rights is a ‘Battlefield’ as Global Discrimination Fuels New HIV Infections 01/08/2022 Kerry Cullinan MONTREAL – HIV is one of the most studied diseases of all time and an arsenal of treatment and prevention tools have been amassed over the past 40 years – the latest being an antiretroviral (ARV) injection taken every eight weeks that can prevent 99% of infections. But HIV is still spreading – primarily amongst […] Continue reading -> ‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Human Rights is a ‘Battlefield’ as Global Discrimination Fuels New HIV Infections 01/08/2022 Kerry Cullinan MONTREAL – HIV is one of the most studied diseases of all time and an arsenal of treatment and prevention tools have been amassed over the past 40 years – the latest being an antiretroviral (ARV) injection taken every eight weeks that can prevent 99% of infections. But HIV is still spreading – primarily amongst […] Continue reading -> ‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Exclusive: Closure of World’s Only Manufacturing Plant for Monkeypox Vaccine Raises Questions About World’s Ability to Meet Rising Demand 31/07/2022 Stefan Anderson & Elaine Ruth Fletcher The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, closed its European vaccine production plant this spring and won’t reopen again until late 2022 – leading to a global monkeypox vaccine shortage, Health Policy Watch has learned. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how […] Continue reading -> AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AIDS Conference Activists Protest ‘Systemic Racism’ Behind Canadian Visa Denials to African Delegates 29/07/2022 Kerry Cullinan MONTREAL – Activists took over the stage at the opening of the International AIDS conference in Montreal on Friday morning to protest Canada’s denial of visas to hundreds of delegates, primarily from Africa, and the inequality and lack of funding that is driving new HIV infections. South African activist Vuyiseka Dubula, former head of the […] Continue reading -> Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pandemic Eroded Vaccine Coverage; Now Signs of Recovery Emerging, but Not Enough 29/07/2022 Raisa Santos Two years of the COVID-19 pandemic led to a cumulative 5% decline in basic vaccine coverage and disrupted routine immunizations globally from 2020 – 2021, reports a new analysis of the state of routine immunizations across 57 lower-income countries. The analysis, by Gavi, the Vaccine Alliance, indicates that signs of recovery are beginning to emerge […] Continue reading -> Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma Deal Enables 90 Countries to get Access to Cheaper HIV Prevention Injectable 29/07/2022 Kerry Cullinan MONTREAL – Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection. CAB-LA’s manufacturer, UK pharmaceutical company ViiV, has given the license to the Medicines Patent Pool (MPP) for patents in least-developed, low-income, lower-middle-income […] Continue reading -> Posts navigation Older postsNewer posts